
He worked with artificial limbs for decades. Then a lorry ripped off his right arm. What happened when the expert became the patient?
Ashworth-Beaumont, a super-fit and sunny former Royal Marine from Edinburgh, would go on to spend six weeks in an induced coma as surgeons raced to repair his crushed body. But as he lay on the road, waiting for the paramedics, his only thoughts were that he was dying. He did not have the wherewithal to consider the irony of his predicament.
In the late 1990s, after he had left the marines, Ashworth-Beaumont, now 59, studied for a degree in prosthetics and orthotics at the University of Strathclyde in Glasgow. Clinicians in these disciplines help patients with pain, function and mobility by making and fitting devices such as prosthetic limbs and orthotic braces. He had written research papers and trained prosthetists while specialising as an orthotist at the Royal National Orthopaedic hospital (RNOH) in north-west London. 'Now I was the patient,' he says.
I meet Ashworth-Beaumont for the first time in Greenwich Park, near the south London home he shares with his wife, Keri, a solicitor he met on a night out in 2002. It's early summer 2024, almost four years after the accident in nearby Catford. He speaks softly through a smile that cracks only when he considers how far he has come and the support he has had: 'Without Keri, I think I would have sat in a corner and wasted away.'
At first, his missing arm was a low priority for Edmund Fitzgerald O'Connor, the plastic surgeon who attended to his horrific abdominal injuries. But, by another twist of fate, the ambitious surgeon, who is 47, had a particular interest in limb loss. For years, he had been searching for the perfect candidate for a radical procedure he wanted to begin offering to amputees.
Osseointegration (OI), or direct skeletal fixation, is a relatively new way to attach prosthetic limbs. Rather than rely on a socket moulded to fit over a residual limb or stump – a method that dates back centuries – arms or legs are attached to a titanium implant inserted into the surviving bone ('osseo' means bone). Fixing a prosthesis to the implant, which emerges from the stump like a little tusk, is as easy as changing a camera lens.
OI patients need no longer tolerate irritation or infection where the socket rubs against skin and flesh. They gain a fuller range of motion and improved control and proprioception – the innate sense of where we and our extremities are in space. A prosthesis becomes part of the body rather than an awkward appendage. 'It feels like I've got my own leg back,' Hanneke Mooij, a Dutch secretary, tells me three years after receiving an implant following decades of torment from ill-fitting sockets.
At the same time, rapid advances in electronic limbs mean surgeons can now effectively wire them into the brain. Taken together, OI and the latest prosthetics appear to bring a bionic future within reach. But the technique's evolution has also been fraught, limiting its adoption. In a small number of cases, implants or bones have cracked. Painful infections have taken hold in the fleshy hole that surgeons must create around the implant. OI is also very expensive at a time when amputees struggle to access basic prosthetics care.
Fitzgerald O'Connor is convinced more of the 25,000 patients seen by the NHS prosthetics service each year could benefit from OI. When we first meet, the National Institute for Health and Care Excellence (Nice), the body that issues guidance on NHS treatment and funding, is reviewing OI. 'When you're doing 15 to 20 amputations a year and you have patients coming back with recurrent problems with their stump, it's saddening to know there's a viable alternative they can't access,' he says.
The surgeon had been building a team to start offering OI, in the private sector at first, when he got the call from King's. He had been searching for a patient who was resilient and in good health, who could help drive wider acceptance of the technique. If Ashworth-Beaumont could fund his treatment, his professional knowledge of what it takes to come back from a traumatic amputation would be a bonus. 'You couldn't have made up a better candidate,' Fitzgerald O'Connor says. 'The conversation started in my mind the day he came in, but I wasn't going to bring it to him until I knew he would survive.'
Osseointegration relies on a process that was discovered by accident. In the 1950s, Per-Ingvar Brånemark, a Swedish scientist based in Gothenburg, put optical devices housed in titanium into the legs of rabbits to observe the way bones heal. Once the study was over, the metal had fused to the bone and couldn't be removed, defying conventional wisdom about the body's tendency to reject foreign objects.
The discovery inspired Brånemark, who died in 2014, to invent dental implants, first used in the 1980s, that fuse to the jaw with titanium screws, removing the need for dentures. Wondering if the bond could hold larger devices, Brånemark and his son, Rickard, an engineer training as an orthopaedic surgeon, designed a larger implant. In 1990, they screwed two into the above-knee stumps of a woman who had been run over by a tram.
The procedure was eye-catching, evoking scenes from science fiction – Star Wars or The Six Million Dollar Man. It was also divisive. 'I remember lecturing in the US in the late 90s when this senior professor stood up and said, 'Only an idiot can believe this will ever work,'' says Rickard Brånemark, 65, who founded Integrum, the first OI company, in 1998. But a handful of enterprising surgeons saw an irresistible logic in bone-anchored prosthetics. Integrum soon had competition.
In Sydney, Australia, Munjed Al Muderis, an Iraqi-born orthopaedic surgeon who had fled Saddam Hussein's regime after refusing to cut off the ears of draft dodgers, developed his own device, which he first implanted in 2008. He says patients have received more than 2,000 of his implants, which are hammered rather than screwed into bone. (Brånemark says surgeons have installed more than 700 Integrum devices.)
Al Muderis, 52, is the technique's most bullish advocate. He is now offering it to victims of vascular conditions including diabetes, the biggest cause of leg amputations. (Other surgeons typically turn down such candidates, fearing their rehabilitation could be hampered by lifestyle factors.) 'There is a big opportunity for this technology to take over from the traditional socket-mounted prosthesis,' Al Muderis insists via Zoom as he changes out of his scrubs.
The surgeon tells me about a current case he says demonstrates OI's potential – a seven-year-old Iraqi orphan who lost an arm in a roadside dog attack while he slept. He was later adopted by a wealthy Chinese family. In the coming months, Al Muderis plans to fit the boy with an implant, which will need to be replaced as he grows. Unlike other OI surgeons, he argues that children can be suitable candidates despite the need for further operations. In the case of leg amputees, he says, OI gets children walking again sooner. 'It's all a balance,' he adds, pointing out that sockets in children need changing a lot more often than OI implants.
The boy will also undergo a procedure called targeted muscle reinnervation (TMR), which involves rerouting amputated nerves. This can help relieve pain in the stump, where the severed nerves can thicken into tumour-like neuromas. Remarkably, it can also help amputees control prosthetic limbs with their minds.
To achieve this, Al Muderis will surgically attach the severed nerves, which had travelled to muscles in the boy's arm and hand, to small, inessential sections of muscle in his chest instead. Tiny electrodes implanted under the skin will connect these muscle sites to the prosthetic arm via eight cables wired through the body and the titanium implant. When the boy moves to grab a water bottle, his brain will activate the chest muscles, which will forward the signal to the corresponding motors in his arm and hand. 'It's amazing because the transmission is instant,' Al Muderis says of TMR, which he adds is not yet widely available.
Integrum has also adapted its implants to allow amputees to upgrade to TMR and other advanced control systems in the future. Yet Al Muderis – who, like Brånemark, has been to Ukraine to offer OI to injured soldiers – says scepticism holds back the technique, including in the UK. He partly blames regulations and resistance to the idea of an implant that perforates the skin: 'This is a completely revolutionary technology which violates many of the principles of orthopaedics.'
Brånemark is more conservative but also thinks far more amputees could benefit than the few thousand globally who have implants. When Fitzgerald O'Connor told him about his plans and the unlikely case of the one-armed prosthetist, the Swedish surgeon agreed to back his British OI team and oversee its first operation. 'A lot of people still don't know about OI, even in Sweden,' Brånemark says. 'As someone who also works in the field, Ashworth-Beaumont can be a really good advocate.'
For weeks, HIs life hung in the balance. He had lost almost all liver and kidney function. Sepsis set in as he lay in a coma. His first wife and their two grown-up children came down from Scotland to say goodbye. 'The first thing I remember, coming out of the coma, was my daughter's face; it's still a really strong image in my mind,' Ashworth-Beaumont says. He thinks he inherited his fighting spirit from his father, a docker's son from Liverpool, who worked as a bellboy before becoming a successful restaurateur. His mother still runs a gift shop in her 80s. He also has childhood memories of a cousin who lost his legs in a car crash. 'I guess amputation was always on my radar,' he says.
After struggling to focus at school, at 16 he joined the marines, where he excelled. Fitness was a passion, and he became skilled in mechanical and electronic engineering, which led to his prosthetics career. In the final year of his degree, begun in 1996, he worked at Steeper, a British prosthetics firm that would one day supply his motorised elbow. He joined the RNOH in 2005 while racing in triathlons and moonlighting as a personal trainer. He was at peak fitness when the lorry hit him.
Sign up to Inside Saturday
The only way to get a look behind the scenes of the Saturday magazine. Sign up to get the inside story from our top writers as well as all the must-read articles and columns, delivered to your inbox every weekend.
after newsletter promotion
While amazed to be alive, Ashworth-Beaumont realised his limitations as soon as he tried to shift his weight around in his hospital bed. 'I knew these things professionally, but it really brings it home when you first try to move your shoulder and nothing happens.' As his vital organs rallied, he became determined to return to work. He would need a highly functional prosthesis; his job is physical, requiring the manipulation of limbs, as well as the making and fitting of devices. He was all ears when Fitzgerald O'Connor shared his plans. He also knew it would take time, and that the advice in prosthetics care is to try standard devices first.
It was almost a year after his accident, when he was about to return to work, that Ashworth-Beaumont received a body-powered arm on the NHS. These mechanical devices are a step up from static prostheses, which can incorporate hooks or skin-coloured hands. By rounding his shoulders, he could open a metal claw attached by a cable to a back harness: 'It works, but the technology has been around for hundreds of years.'
Socket attachments date back to the 16th century or earlier. Designs and materials have changed, but the principle is the same: a socket must grip the stump for good function but not so tightly as to cause discomfort. Suction helps keep a socket on, but Ashworth-Beaumont needed strapping to pull his against his short stump, which further limited comfort and mobility. He ended up wearing the arm for just a few hours a day at work, and describes a circular problem for arm amputees. The motivation to use a prosthetic leg is high, to avoid relying on crutches or a wheelchair: 'But there's so much we can still do with one arm.' Patients tend to get frustrated with prosthetic arms, often stashing them away and making do. Ashworth-Beaumont says this partly explains a reluctance in the NHS to offer advanced devices, particularly early on. 'But the problem is they're also not giving people the opportunity to try these components when so many of us would benefit.'
He went private to get a better arm sooner, using money raised from a legal settlement with the lorry company and a family crowdfunder. Working with Alan McDougall, a prosthetist at Proactive, a private clinic in Surrey, he upgraded to a stealthy black electric device with motors in the elbow, wrist and hand. He learned to flex his residual biceps and triceps independently to activate the motors, via sensors built into the socket. Subtle hand movements allowed him to adopt different grips. It's a step below TMR, but it works: I see it in action when we next meet and Ashworth-Beaumont gives me one of the firmest handshakes I've had.
The electric arm, which is worth more than £100,000, meant he could do more, but it further exposed his socket's shortcomings. It was heavier than the NHS device, requiring a tighter, less comfortable fit. He could pick up a mug, say, but the flesh interface also made it hard to position the hand precisely, creating a lag between brain and hand. OI increasingly felt like the solution. Ashworth-Beaumont considered himself an overqualified guinea pig with an opportunity to highlight his profession and widen access to the latest tech. 'I see it almost as a duty to explore the possibilities,' he told me in 2021, when I first got in touch.
Ashworth-Beaumont would not be the first British amputee to receive an Integrum implant. Starting in the late 90s, Brånemark's new devices were used in a trial involving 18 patients at Queen Mary's hospital in Roehampton, south-west London, where the modern British prosthetics industry emerged after the first world war. While the trial had some success and provided valuable data, the experience of its least fortunate participants still reverberates around the field and the debate about NHS provision.
Gemma Trotter, a fitness instructor from south London, was 16 when she had a leg amputated above the knee after a car crash. Held back for years by uncomfortable sockets, she set aside her reservations about OI, which she had viewed as 'crackers', and joined the trial in 2003, aged 21. It was transformative. 'Suddenly I could feel the floor through my leg again. If I wore jeans, a lot of people didn't even know I was an amputee,' she says. 'I got married, had a baby … they were the best nine years of my life.'
Then the implant broke and became infected. By then the trial team had disbanded, limiting follow-up care. Trotter, now 42, has endured more than a decade of pain and attempted fixes by surgeons including Brånemark. She is waiting to have her third implant removed after more problems, and won't risk having another. (Brånemark tells me that, while there is a risk of failure with any implant, Integrum's success rate has significantly improved since the Roehampton trial.)
Trotter remains one of only a few dozen patients in the UK who have had OI, which is more widely available in countries with insurance-based health systems. Hanneke Mooij, the Dutch patient, is surprised to hear OI is hard to access in the UK. She received an Integrum device in 2022, 36 years after losing her leg in a motorbike crash. She is part of a Dutch group of 20 one-legged female friends who call themselves 'the flamingos', half of whom have had OI surgery in the past few years. 'I'm convinced this is the future,' she says.
Most British OI recipients are patients at Relimb, a private clinic founded at the Royal Free hospital in north-west London in 2018. Its directors, Norbert Kang and Alex Woollard, use Al Muderis's implants and have about 60 patients on their books, almost all funded by legal settlements after traumatic accidents. Partly with the Roehampton trial in mind, they do not think the NHS has the resources to offer the skilled and long-term care required to make OI successful. 'No matter how beneficial it is and how well we can do it now, we're not going to change health economics,' Woollard says.
He and Kang are not alone in having doubts. Nicky Eddison, chair of the British Association of Prosthetists and Orthotists, says the professions are already facing a staffing and recruitment crisis, and some NHS trusts are making do with just two specialists. 'Whatever technical advances you make, we can't deliver them without skilled clinicians,' she says.
Yet proponents of OI make a case for long-term cost savings. Stephen Cruse, founder of the Amputation Foundation, a charity in Merseyside, had OI surgery with Al Muderis in 2016, eight years after losing his legs in a car crash while in Australia. After returning to the UK, he convinced an Australian government compensation scheme to fund his surgery after calculating it would save money in five years. 'They were paying about £30,000 a year on sockets, liners and maintenance,' says Cruse, who had a 'nightmare' with sockets but now rarely needs to see his prosthetist.
Last December, Nice published new guidelines. It now recommends that OI can be used in the NHS but only by multidisciplinary teams with specific training, and the NHS tells me its policy – not to offer it widely – isn't changing, based on the risks and its funding priorities. Fitzgerald O'Connor says there may be ways to secure funds in exceptional cases, and he will continue to push for wider access as evidence of OI's efficacy grows. 'To leave it in a silo, where it's only accessible with vast amounts of money, does a disservice to patients who are suffering,' he says.
After long delays caused by Covid and post-Brexit paperwork, Ashworth-Beaumont finally gets a date for his private surgery: a Saturday in October 2024. 'I tend to take things in my stride, but it feels like jumping out of a plane,' he tells me a few weeks before the operation. 'You know the systems are there to protect you, but there's always that 1% chance things could go awry.'
The day before the surgery, which will take place at St Thomas's hospital in central London, I join Ashworth-Beaumont at a private clinic farther up the Thames at Battersea power station. Fitzgerald O'Connor and Aaron Saini, an orthopaedic surgeon who is also part of the new OI team, have gathered amputees and professionals to discuss this case and prosthetics technology more widely. The subject of NHS care keeps cropping up.
Craig Mackinlay, a former Conservative MP from Kent, lost all four limbs to sepsis in 2023. Five months later, he received a standing ovation when he strode into the House of Commons wearing prostheses. Fitzgerald O'Connor, who performed the amputations, looked on from the public gallery. It was a triumphant comeback, but Mackinlay has since highlighted NHS shortcomings, including long waits and early black rubber prostheses that resembled 'clubs … I couldn't see what they'd be good for apart from breaking windows or pub fights.'
Mackinlay, now a life peer, has since gone private, with support from device firms and his own money. In a debate in the Lords this May, he said he would still be in a wheelchair had he not accessed better legs sooner. 'The technology is out there and the NHS will give some of it to you, but it takes years,' he says. 'Why are we holding people back?' In response, Baroness Merron, a health minister, announced a review of the provision of advanced prostheses. In a statement, an NHS spokesperson insists that it 'provides a comprehensive package of care and support for people who have lost limbs, including a range of prosthetics'.
When I ask Ashworth-Beaumont if everything is starting to feel a bit real, he takes a deep breath. 'This is all positive,' he says, his voice cracking. 'Sorry, I'm just thinking about the last four years.' Fitzgerald O'Connor places a hand on his shoulder. 'It was tough, but you made it,' he says. The next morning, Brånemark, Fitzgerald O'Connor and Saini screw the Integrum implant into Ashworth-Beaumont's humerus, carefully rebuilding his soft tissue around it. 'I've been walking around like I'm made of crystal,' he tells me two days later via Zoom as he waits for bone and metal to bond.
Not long after Christmas, he is ready for an arm. McDougall has adapted Ashworth-Beaumont's body-powered device so he can attach it to his implant. Even with the encumbrance of the cable and harness needed to move the hand, he is struck by the enhanced control of a firmly anchored limb. 'I went out for dinner with Keri for my birthday and used a knife and fork properly,' he says. 'I feel more competent as an individual.'
By early March he is ready to go full bionic, connecting his heavier electric arm. At Proactive, plaster casts of stumps stand like sculptures in the workshop. As well as adapting the more advanced arm, McDougall has added a small cuff to house the muscle sensors that used to sit inside Ashworth-Beaumont's socket. The arm would look at home in a sci-fi props department, with its carbon fibre-effect shell and translucent glove, which reveals some of the hand's moving parts. Then there's the gap in the upper arm, where only the titanium implant links flesh to hardware. Yet when the prosthesis hangs from Ashworth-Beaumont's shoulder, it somehow looks like part of him. Without the socket and straps, his silhouette is symmetrical: he is whole again.
Soon motors whirr as he tests his bionic joints, raising his arm above his head in a way he hasn't been able to do since the accident. McDougall adjusts it using a Bluetooth-connected iPad app. 'This is really good,' Ashworth-Beaumont says as he picks up a stray screw from a workbench. Within days, he's performing tasks previously beyond him. Hoovering feels like a privilege.
Five years after his old arm appeared to wave goodbye, Ashworth-Beaumont is as aware as anyone of the limitations of the health service. 'I've spent, what, five hours with Alan today, there's no way you'd get that time in the NHS,' he says. While he watches the OI debate continue, returning to his own NHS job has felt like his biggest achievement. As well as being able to meet the physical demands of his work, his ordeal has changed his relationship with patients. 'I was quite emotional about it after my first few appointments,' he says. 'I really did know how they felt.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
23 minutes ago
- Daily Mail
How US doctor helped fuel public fears over 'toxic' sunscreens as reality star Sam Faiers faces backlash for not putting cream on her three children
When reality TV star Sam Faiers revealed last week her children don't wear sun protection, she became the latest celebrity to claim that sunscreens are 'harmful' and full of 'toxic ingredients'. Posting to her 2.5million followers on Instagram, the former The Only Way Is Essex star, 34, shared photographs of her children Paul, nine, Rosie, seven, and Edward, two, as they holidayed in Majorca. She wrote: 'My whole family don't actually wear sunscreen. 'Over the years, the kids have built up a really good tolerance to being in the sun. 'Of course, if it's really hot and the sun feels too harsh, I'll make sure we head into the shade… I'm really careful about sunscreen in general, because a lot of them are actually pretty harmful and full of toxic ingredients.' Other celebrities have adopted the same approach: influencers Kelsey Parker and Lauryn Goodman have told their followers they ignore NHS advice to wear sun protection factor of at least 30. Health experts are horrified at what they see as a dangerous conspiracy theory, fearing a fall in sunscreen use will lead to a rise in skin cancer. According to market researchers Mintel, 72 per cent of UK adults used sun protection in the 12 months to September 2024, falling from 77 per cent in the same period in 2023. So, how did the worrying pseudo-science about sunscreen take hold? The Mail on Sunday has traced its genesis back to a scientific paper published in the Journal of the American Medical Association and posted on Twitter in May 2019. The paper, by 19 scientists, tested four sunscreens on the market and found the concentrations of some chemicals exceeded thresholds established by the US Food and Drug Administration. It made clear further studies were needed to determine the clinical significance: 'These results do not indicate individuals should refrain from the use of sunscreen.' But the next day, New York medic Dr Tro Kalayjian, a specialist in obesity, stepped into the debate. He reposted the paper and told his 158,000 Twitter followers: 'Have said this many times now: Be careful what you smear on yourself and your children.' Over the next six years, the 2019 paper – Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients – has become one of the most hotly debated scientific works on Twitter and social media site BlueSky. Just last month, Dr Tro, as he refers to himself online, wrote on the website of his company Toward Health: 'Our skin and our gut are literally the physical ways our bodies interact with the world. 'They're how we absorb sunlight and nutrition… but also how toxins, heavy metals, parasites, plastics, and chemicals make their way into our bodies.' He added: 'I often tell patients, 'If you wouldn't trust it inside your body, think twice before putting it on your skin or in your mouth'.' While Dr Tro does not advise against all sunscreens, he says some – like other cosmetics – contain harmful substances. He says barriers such as clothing, hats and shade should be considered. He founded Toward Health, which specialises in obesity treatment and diabetes management in New York in 2017 after losing 150lb on a low-carbohydrate diet. Dr Tro told The MoS: 'I understand those who deeply value public health messaging may struggle with the idea previously recommended practices can become outdated or even unsafe. 'It can feel more comfortable to trust the guidance as-is and view any challenge to it as fearmongering or misinformation. 'But the truth is, these issues are complex. People benefit most when they think critically and independently. Public health messages are important and should be heard, but should also be open to question, especially when the science evolves faster than the guidelines.' UK doctors dismissed the scares. Skin cancer prevention doctor Ross Perry said he is 'horrified' by influencers' comments, calling Ms Faiers 'naive and irresponsible'. Dr Perry told The MoS: 'Children do not build up a tolerance to sun exposure – they are just storing up more sun damage for later on in life. 'It is a well-known fact if children get any degree of sunburn, it more than doubles their risk of getting skin cancer at a later date so that is completely false and misleading. 'Remember any tan or sunburn is creating damage to the skin so SPF should always be worn in the sun.' HOW TO STAY SAFE IN THE SUN To stay sun safe, experts recommend people: Seek shade between 11am and 3pm, which is when the sun's rays are typically strongest Wear at least SPF 30 sunscreen Apply sunscreen 30 minutes, and again just before, UV exposure Opt for water-resistant sunscreen if necessary and reapply after swimming, sweating or using a towel Cover up with protective clothing, a wide-brimmed hat and sunglasses Be extra careful with babies and young children. Infants under six months should be kept out of direct sunlight Do not use sunbeds or sunlamps Checks moles and skin for any changes


The Guardian
an hour ago
- The Guardian
UK has got ‘fat' on decades of free labour by women, says MP Jess Phillips
Labour MP Jess Phillips has said the UK has got 'fat' from the free labour of women for decades. The minister for safeguarding and violence against women and girls said the country has relied on women providing charity, adding it was a 'fundamentally sexist' practice that meant the government was less willing to provide the service itself. She said she 'hated' the title of her role and added that safeguarding against gender-based violence should be 'business as usual in every single government department'. The Birmingham Yardley MP also suggested there was an issue in Whitehall where government departments viewed violence against women and girls as solely a Home Office issue. Phillips said she had to push for the safety of women and girls to be a 'mainstream concern', which she said had not always made her 'popular as a government minister'. Asked what pushback she had received from ministers or civil servants, she said: 'People directly say things like, 'That's the Home Office's job'. 'Why is it my job to do healthy relationship education in schools? Why is it my job to provide mental health support for whatever reason it is that you ended up in that [situation]?'. 'Do you know what it is? Free labour of women is where it comes from. 'It comes from a fundamentally sexist place in that women didn't have these services, so a load of women across the country got together and made these services and offered them to other women for free, and they didn't get paid for their labour. 'So they put down a mattress and made a refuge. They set up counselling services and got people who were trained to be therapists and got their voluntary hours and set it up for free.' Phillips said people do not recognise how heavily the UK has relied on women providing support that previously did not exist. She added: 'Nobody offered diabetes medicine for free. Pharmaceutical companies didn't go, 'Wow, this is really important. People will die without this. We'll just give it away for free'. 'That is what the women in our country did in the 1960s and 1970s and 1980s and we got fat on that expectation that that service will be provided for free. 'And we also belittled it as an issue that wasn't absolutely, fundamentally mainstream to the safety and security of our nation. 'Undoing that is really hard and it's going to take a long time.'


Daily Mail
an hour ago
- Daily Mail
Private equity barons extracting millions from our dentists
Private equity sharks are cashing in on the crisis in NHS dentistry with debt-fuelled firms taking big bites out of the sector – including one advised by a former Health Secretary. The latest entrant is Bridgepoint, which previously owned care home operator Care UK, and has spent a reported £800 million buying a majority stake in MyDentist. MyDentist, which runs more than 500 practices, has a 5 per cent share of the UK market and is the biggest chain providing NHS services. Bridgepoint's advisors include former Labour Health Secretary Alan Milburn, recently appointed lead non-executive director at the Department of Health and Social Care. The UK-based firm's chief executive Raoul Hughes could earn a bonus of more than £2.5 million this year on top of his £850,000 salary, up from £1.6 million last year. Fears have been raised about the impact on patient care of chains – most owned by profit-hungry, private equity – now running 12 per cent of practices, and even whether they will attempt to 'hold the Government to ransom' for payments. Already, the cost of a basic filling at one leading private equity-owned chain is three and a half times the amount charged by an NHS dentist. There is concern the sector could end up in the same position as care homes and veterinary services, where prices have soared amid private equity domination. Fatal extraction: There is concern the dental sector could end up in the same position as care homes and veterinary services The Centre for Health and the Public Interest think-tank published research in May showing £1.5 billion is taken out of the care home sector each year in returns to shareholders and investors. Meanwhile, a paper in the British Medical Journal said ownership by big business pushed up prices and had 'mixed to harmful impacts' on patient care. Separately, the Competition and Markets Authority is conducting an ongoing investigation into pricing at veterinary practices, 60 per cent of which are now controlled by big chains, several of which are private equity-owned. Health Secretary Wes Streeting has pledged urgent reform of dentistry as the number of people to have seen an NHS practitioner in the past two years fell to just 40 per cent. Some areas of Britain have been deemed 'dental deserts' with no NHS dentists for miles and a severe lack of capacity even at private clinics. It comes amid a shortage of dentists wanting to take on health service work due to a disastrous contract imposed almost two decades ago by New Labour. The journal Healthcare Business International has described UK dentistry as 'ripe for consolidation with single and dual practices still dominant'. It predicts there is 'room for growth' by big firms. Other private equity-backed chains are Portman Dentex and Rodericks – whose ownership by firms with links to the tax havens of Luxembourg and the Cayman Islands respectively has sparked unease among senior MPs and campaigners. Dennis Reed, of older people's rights group, Silver Voices, said he feared the 'extinction of NHS dentistry', adding: 'In private residential homes prices are astronomical because they are owned by these large groups, hedge funds and private equity companies, which are driving up costs. I would hate for dentistry to go the same way. 'If they take over, private prices will go up and they will hold the Government to ransom for NHS dentistry too, demanding more and more money.' Labour MP Clive Betts, deputy chairman of the Public Accounts Committee, called the arrival of private equity chains 'extremely worrying'. He said: 'The best way to stop them is to get the NHS dental contract sorted out so dentists get a fair return and patients can get an available service.' In a report published in April, the committee warned there was 'no future' for NHS dentistry without 'fundamental reform'. In June, delegates at the UK's largest gathering of dentists called for an 'urgent assessment' of the 'growing dominance' of private equity firms. The Local Dental Committees' conference in Newcastle passed a motion saying: 'We believe that the interests of private equity providers are rarely aligned with this profession, and there is an urgent need for an assessment of the risk associated with their growing dominance of private and NHS care.' Insiders said there was concern that other private equity bidders for MyDentist had included TDR Capital, which has been accused of loading firms with debt, and Cinven, which was fined three times for price fixing on NHS drugs. Dentists are also concerned that 'efficiency savings' typically sought by private equity groups risk 'a clear and present danger to the delivery of ongoing care'. Dr John Puntis, a retired consultant paediatrician and co-chair of Keep Our NHS Public, said: 'Since the disastrous dental contract under New Labour, many dentists found practices financially unviable, opening up a vacuum increasingly filled by private companies. 'Meanwhile, more dental deserts have been created where people can no longer find an NHS dentist. 'Reports of 'do it yourself' dentistry have become increasingly common, and cases of oral cancer have also risen as routine dental checks on the NHS have fallen. 'Private dentistry is beyond the means of many, with poor oral health strongly associated with low income and deprivation. What is needed is a commitment from Government to bring dentistry back into the NHS, adequate funding, and a new contract for NHS dentists that is financially fair and focused on prevention. Were this to happen, the growth of private equity firms would shrink greatly and oral health would improve.' In May, the British Dental Association warned MPs that NHS dentistry faced an 'existential threat'. In a paper presented to Parliament, it said while the number of qualified dentists was at a record high, there were 'only enough dentistry commissioned for half the population'. It said: 'We are seeing a return of scenes that belong in the Victorian era, with new polling from Ipsos indicating that of those unable to secure an NHS dental appointment a quarter resort to DIY dentistry, with almost 1 in 5 seeking help abroad.' Chairman Eddie Crouch said: 'As we see more churn in the financing of these big chains it is more important than ever that the interests of patients remain at the forefront of care rather than a quick return on investment, whether in NHS or private provision.' MyDentist, previously owned by Palamon Capital Partners, last year saw turnover rise £39 million to £573 million and its profit before interest and tax rise 14 per cent from £73 million to £84 million. The company's debt rose from £328 million to £362 million, with interest payments eating into its profits, which fell from £16 million to £6 million. Though MyDentist's accounts boast of attracting 22.5 per cent more NHS patients, the amount of NHS work fell in monetary value from £313 million to £301 million between 2023 and 2024. Profit growth mostly came from a boom in private treatment, which grew from £221 million to £272 million. Alan Milburn is paid for corporate advice via his consultancy firm AM Strategy, with he and his family having received dividends of more than £5 million between 2017 and 2023, according to Companies House records. The most recent accounts for the 12 months to March last year showed the company's assets had grown from £5.3 million to £6.2 million. As well as Bridgepoint, the former New Labour politician has been a longstanding advisor to consultancy PwC's health practice, confectionery giant Mars and US healthcare firm Centene Corporation. An MP until 2010, he received £25,000 a year to sit on the board of Lloyds Pharmacy, and £20,000 a year on the advisory board of PepsiCo UK, according to the register of members' interests. After My Dentist, the second biggest chain – all of which offer NHS treatments – is Bupa, with 389 practices. Last year, the firm's overall pre-tax profits soared 72 per cent from £564 million to £972 million. The company is due to announce its latest half-yearly results on Thursday. Next is Portman Dentex, with 384 practices. It is owned by Belgian-based Core Equity Holdings, which has a linked firm in the Cayman Islands. Its accounts for the year to September 2024 show turnover up 37 per cent from £436 million to £597 million, driven largely by a growth in private treatment from £310 million to £438 million. NHS turnover grew from £81 million to £97 million. Portman Dentex's profit before interest and tax rose from £53million to £91 million. But borrowings rose from £778 million to £883 million, and the firm – which is eyeing a 'pipeline of future acquisitions' – made an overall loss of £82 million in 2023 and £72 million in 2024. Smaller rival Rodericks, owned by London-based private equity firm CapVest, which has offices in Luxembourg, ran 165 practices last year and boasted of a 'focus on delivering NHS contracts and increased private dental treatments'. Its most recent accounts show turnover up £3 million to £82 million in the year to March 2023. The arrival of big business followed New Labour's controversial 2006 dental contract. While dentists were previously reimbursed for individual treatments, the payment system changed so fees were offered for 'units of dental activity' covering types of work. Critics say the move meant individual dentists were left underpaid, receiving a standardised fee for both simple and more complex treatments, prompting an exodus from the NHS. Big chains were attracted because they could provide large volumes of work. Health Secretary Wes Streeting has promised to reform the dental contract. At present, there is no regulatory structure or form of risk assessment for corporate entities buying into dentistry – other than competition rules. A Department of Health and Social Care spokesperson said: 'We inherited a broken NHS dental system and have already begun fixing it – rolling out 700,000 urgent appointments – and our ten-year health plan will fix the foundations of NHS dentistry. 'Reforms to the dental contract will prioritise those with urgent and complex needs, with new measures for those with extreme tooth decay and gum disease. 'We are also committed to ensuring NHS-trained dentists stay in the system for at least the minimum period and all dentists – NHS or private – are registered and regulated by the General Dental Council to ensure patient safety.'